Recap EUDAMED Online Session - MedTech Europe

Recap EUDAMED Online Session - MedTech Europe

I am honored to have been invited as a speaker for the MedTech Europe webinar on EUDAMED, which took place at the end of March. The webinar was organized specifically for the MedTech industry and had over 1,000 registered participants, a...

read more
EUDAMED - mandatory use in Finland!

EUDAMED - mandatory use in Finland!

We'd like to remind you that all medical devices sold in Finland must be registered in EUDAMED (UDI module) - whether new or "legacy devices" - since 2021; and the same will apply to IVD legacy devices by August 2022 already! With atrify, you can easily comply with...

read more
atrify and GS1 Austria strengthen their joint partnership

atrify and GS1 Austria strengthen their joint partnership

We are pleased to announce that the partnership between GS1 Austria and atrify will be strengthened again. Especially manufacturers of medical devices located in Austria can benefit from the close cooperation between GS1 Austria and atrify. From now on, they have the...

read more
EUDAMED - From expertise to solution

EUDAMED - From expertise to solution

The EUDAMED UDI module for the registration of medical devices has been in operation since 4 October 2021 - voluntary from the point of view of the European regulation, mandatory or almost mandatory according to various European member states. Reminder: 5 years...

read more
EUDAMED UDI module live!

EUDAMED UDI module live!

Following the release of the Actor module, which has been operational since December 2020, the UDI and CERTIFICATE modules went live in EUDAMED on Monday 4 October. This is another important step towards the implementation of EUDAMED and the MDR/IVDR....

read more
Updates in the Healthcare Industry

Updates in the Healthcare Industry

There are a number of regulatory changes happening in healthcare right now that companies need to keep a close eye on - and we're here to help. Firstly, changes to the EUDAMED deadlines for the UDI and device registration module will make it easier for the industry to...

read more
Getting ready for EUDAMED go-live in September 2021

Getting ready for EUDAMED go-live in September 2021

EUDAMED, the key element of the Medical Device Directive (MDR) and In Vitro Diagnostics (IVDR) in the European Union, is expected to be released in modular form in the coming months. The so-called actor module will already be released in December 2020.

read more
EUDAMED Actor Registration Live

EUDAMED Actor Registration Live

atrify welcomes the production go-live of the EUDAMED Actor Registration module on 1st December 2020 This is a major milestone towards enabling manufacturers to be MDR and EUDAMED compliant, ahead of the production opening of UDI Device registration and Certificates...

read more
atrify's Collaboration with GridAgent Proving Successful

atrify's Collaboration with GridAgent Proving Successful

We are pleased to announce that ever since GridAgent joined atrify's Partner Program in 2019, our combined strengths have been enabling a growing number of Japanese customers to comply accurately and efficiently with global requirements in the healthcare industry....

read more
Data Integrity is Key for the Medical Device Industry

Data Integrity is Key for the Medical Device Industry

MDM West 2020 in Anaheim US wrapped up a few weeks ago and it was certainly an interesting and informative show. These companies that were present are critical links in the Medical Device supply chain providing a great assortment of specialized products and components.

read more
atrify UDI regulatory user group

atrify UDI regulatory user group

atrifys success is built on working closely together with the community of manufacturers, their trading partners, regulatory bodies, and trade association. To further streamline this approach, we recently transformed our MDR Implementation task force into a regular UDI Regulatory user group.

read more
MDR/IVDR 2d Corrigenda adopted

MDR/IVDR 2d Corrigenda adopted

On 17th December the European Parliament adopted a second correction for MDR and IVDR. This mainly affects some Class I products, for which there is a four-year transitional period (until May 2024) for full transition to MDR...

read more
EUDAMED Test 2019 successfully passed

EUDAMED Test 2019 successfully passed

atrify has tested thousands of devices with 8 participating manufacturers in the first rounds of the EUDAMED tests (Playground 1 & 2). The EUDAMED UDI Playground has been available for three months to facilitate machine-to-machine and third-party data exchange.

read more
EUDAMED: Open letter from the CAMD Executive Group

EUDAMED: Open letter from the CAMD Executive Group

Following the public announcement by the European Commission to postpone the launch of EUDAMED until May 2022, the CAMD Executive Group has prepared an open letter to express its concerns about this development. The CAMD Executive Group stresses that the...

read more

Successful EUDAMED tests with the EU Commission

The European Commission's EUDAMED M2M UDI test has been completed. With 1156 successful UDI transmissions we are the most successful participating connector. A big thank you to our customers, who have worked with us, and to our team - together we were able to...

read more

European Commission designates IVDR Notified Body

The European Commission has appointed DEKRA Certification GmbH as IVDR Notified Body. This is a supplement to the previously named MDR Notified Bodies: BSI UK, TÜV Süd, DEKRADE, IMQ Italy and TÜV Rheinland. The Commission expects that by the end of this...

read more

Latest EUDAMED deadlines

At the last meeting of the Member States with the EU Commission (MDCG Meeting 30 September) the following deadlines were confirmed: May 2020: Date for registration (EUDAMED database opening: March 2020) November 2020: Start of the most important registration...

read more

Successful EUDAMED Tests

Last week atrify carried out the first successful tests with EUDAMED. UDI data was uploaded, sent to EUDAMED and we received the positive confirmation message "success". The tests conducted by the European Commission...

read more

EUDAMED M2M tests have begun

We are in the middle of the M2M test with the European Commission. Our first data sets have been successfully transferred to EUDAMED. The test period lasts until 14 October 2019, i.e. interested companies have two more weeks to participate in the test.

read more
EUDAMED Data Dictionary

EUDAMED Data Dictionary

Manufacturers of medical products should put a big red ring around 26 March 2020 on their calendars. From this date all product data must be stored in the European database, EUDAMED. But how to go about it? Uploading data and maintaining it in the database...

read more